- Home
- ONMD vs FGEN Comparison
ONMD vs FGEN Comparison
Compare ONMD & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONMD
- FGEN
- Stock Information
- Founded
- ONMD 2006
- FGEN 1993
- Country
- ONMD United States
- FGEN United States
- Employees
- ONMD N/A
- FGEN N/A
- Industry
- ONMD
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- ONMD
- FGEN Health Care
- Exchange
- ONMD Nasdaq
- FGEN Nasdaq
- Market Cap
- ONMD 38.9M
- FGEN 45.0M
- IPO Year
- ONMD N/A
- FGEN 2014
- Fundamental
- Price
- ONMD $0.89
- FGEN $11.32
- Analyst Decision
- ONMD
- FGEN Strong Buy
- Analyst Count
- ONMD 0
- FGEN 2
- Target Price
- ONMD N/A
- FGEN $146.50
- AVG Volume (30 Days)
- ONMD 1.6M
- FGEN 37.2K
- Earning Date
- ONMD 08-13-2025
- FGEN 11-11-2025
- Dividend Yield
- ONMD N/A
- FGEN N/A
- EPS Growth
- ONMD N/A
- FGEN N/A
- EPS
- ONMD N/A
- FGEN N/A
- Revenue
- ONMD $459,000.00
- FGEN $7,346,000.00
- Revenue This Year
- ONMD N/A
- FGEN N/A
- Revenue Next Year
- ONMD N/A
- FGEN N/A
- P/E Ratio
- ONMD N/A
- FGEN N/A
- Revenue Growth
- ONMD N/A
- FGEN N/A
- 52 Week Low
- ONMD $0.30
- FGEN $4.50
- 52 Week High
- ONMD $1.56
- FGEN $21.94
- Technical
- Relative Strength Index (RSI)
- ONMD 59.13
- FGEN 54.60
- Support Level
- ONMD $0.82
- FGEN $11.12
- Resistance Level
- ONMD $0.92
- FGEN $12.53
- Average True Range (ATR)
- ONMD 0.07
- FGEN 0.86
- MACD
- ONMD -0.01
- FGEN -0.18
- Stochastic Oscillator
- ONMD 69.51
- FGEN 34.36
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.